Global Women's Health Academy
The Global Women's Health Academy (GWHA)series features late-breaking women's health education from leading clinical and public health experts across the world.
For more information about GWHA, visit www.globalwomenshealthacademy.org.
31-45 of 101
Clinical Outcomes of Radiation vs. Chemoradiation in Recurrent Endometrial Cancer
Advances in Women's HealthClinical Outcomes of Radiation vs. Chemoradiation in Recurrent Endometrial Cancer
Expanding IUD Use Through Tailored Counseling and Pain Management Solutions
Advances in Women's HealthExpanding IUD Use Through Tailored Counseling and Pain Management Solutions
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
NeuroFrontiersPregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
Optimizing Access to Endometriosis Treatment: Strategies for Timely, Effective Care
Advances in Women's HealthOptimizing Access to Endometriosis Treatment: Strategies for Timely, Effective Care
Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Project Oncology®Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Project Oncology®Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
- advertisement
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Project Oncology®Navigating Fertility Preservation in Young Patients With Endometrial Cancer
GLP-1 Baby Boom and Birth Control Failures: Why It's Time to Talk IUDs
Advances in Women's HealthGLP-1 Baby Boom and Birth Control Failures: Why It's Time to Talk IUDs
Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
Project Oncology®Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
Enhancing Efficacy and Safety in HR+/HER2- Breast Cancer with Novel PI3Kα Inhibitors
Project Oncology®Enhancing Efficacy and Safety in HR+/HER2- Breast Cancer with Novel PI3Kα Inhibitors
Targeting PI3Kα-Mutated HR+/HER2- Breast Cancer in the Second-Line Setting
Project Oncology®Targeting PI3Kα-Mutated HR+/HER2- Breast Cancer in the Second-Line Setting
Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
Project Oncology®Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
- advertisement
Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Project Oncology®Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Putting Patients First: Personalized Care in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerPutting Patients First: Personalized Care in Metastatic Breast Cancer
Clinical Decision-Making in Metastatic Breast Cancer: Optimizing Sequencing Choices
On the Frontlines of Metastatic Breast CancerClinical Decision-Making in Metastatic Breast Cancer: Optimizing Sequencing Choices
